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ABSTRACT
Objective: In 2015, 9.6 million people around the world became sick with tuberculosis (TB) disease and 1.5 million TB-related deaths worldwide. 
Recent increasing incidence of multidrug-resistant (MDR; resistance to at least rifampicin (RIF) and isoniazid [INH]) and extensively drug-resistant 
(MDR resistance plus resistance to a fluoroquinolone and an aminoglycoside) makes TB a serious concern. Lot of research is needed to deal with this 
infectious disease for a better alternative in treatment or modification of these older TB drugs. The present study aimed at evaluating antimycobacterial 
activity of norbornene (NOR) derived INH copolymer with poly ethylene glycol (NOR- polyethylene glycol [PEG]-INH) a novel nanocarrier along with 
the anti-TB drug using luciferase reporter phages (LRPs).
Methods: NOR derived INH accounts for 74% of INH, 24% of NOR, and 2% of PEG. H37Rv control strain, a sensitive, and a resistant strain of 
Mycobacterium TB (MTB) used in this study. The in vitro activity of the drug was evaluated using absolute concentration method. The resistant strain 
was evaluated using LRP assay to observe the minimum inhibitory concentration of the drug.
Results: Reduction in light units was observed for the resistant strain exposed to plain INH and NOR-PEG-INH separately. 24% of reduction was 
observed in strains exposed to plain INH whereas 37% of reduction was observed in strains exposed to NOR-PEG-INH.
Conclusion: NOR-based INH had better antimycobacterial activity compared to plain INH and RIF. Antimycobacterial activity of INH and RIF increases 
even with very low dosage with NOR conjugate.
Keywords: Norbornene, Antimycobacterial activity, Minimum inhibitory concentration, Mycobacterium tuberculosis.
INTRODUCTION
Tuberculosis (TB) is considered as the deadly disease of the past and 
present in the earth [1]. The current TB chemotherapy under directly 
observed therapy short course even though highly efficient, control 
of TB is highly challenging [2]. Long duration and complexity of the 
chemotherapy results in non-adherence to the treatment leading to 
crucial response such as failure or relapse or multidrug-resistance TB 
and extensively drug-resistant TB in patients [3]. Newer anti-TB drugs, 
namely, delamanid, bedaquiline, and pretomanid has a good synergistic 
effect but attempts to shorten the course of treatment with these 
alternative drugs resulted in severe adverse effects [4,5].
At present, there is a pressing need to improve treatment by either 
enhancing the application of existing agents with nanocarriers or 
introduction of the new drugs which shorten the treatment. The 
drug delivery systems have produced novel solutions to reduce the 
side effects and duration of treatment using these four drugs through 
nanotechnology [6].
Nanotechnology is a technology which uses materials of nanometer 
scale length (1-100 nm) can be used for a broad range of 
applications and the creation of various types of nanomaterials and 
nanodevices [7]. Nanotechnology has provided a huge development 
to pharmacology through the designing of drug delivery systems. 
Polymers act as a nanocariers for drug delivery [8,9]. Norbornene 
(NOR) derived doxorubicin polymeric micelle with hydrazone 
linker shows excellent performance inside the cell as an efficient 
drug delivery system and longer bioavailability. NOR derived 
thiobarbiturate homopolymeric symbolize themselves as 
promising carriers for the stimuli triggered intracellular delivery of 
hydrophobic drugs [10-12].
NOR derived anti-TB drugs can be a multi frontline TB drugs for 
potential therapeutic treatment. It has stability under physiological 
condition and depending on acidic pH condition the drug releases 
and has the feasibility of potential drug delivery in macrophage 
compartments [13]. The interaction of NOR along with isoniazid (INH) 
toward Mycobacterium TB (MTB) has to be studied detailed with drug 
susceptibility testing (DST). Various phenotypic methods are utilized 
for DST of MTB including absolute concentration method (ACM), 
proportion method, resistance ratio method, alamlar blue assay, and 
luciferase reporter mycobacteriophage (MP) assay [14].
Luciferase reporter phage (LRP) assay involves viable mycobacteria 
infected with reporter phages (phAETRC21) expressing firefly 
luciferase gene. Light production requires metabolically active MTB 
cells, in which reporter phages replicate and luciferase gene will be 
expressed. Drug-susceptible MTB strains with specific anti-TB drugs, 
fail to produce light after infection with LRPs but drug-resistant strains 
are unaffected by the drugs and produce light similar to the strains 
which are not exposed to drug (control) [15]. The aim of the study was 
to evaluate the efficacy of NOR anti-TB drugs susceptibility testing on 
MTB using Luciferase reporter MP.
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METHODS
The plain nanocarrier with INH was procured from Department of 
Polymer Chemistry, IISER, Kolkata, India. INH attached to the NOR 
monomers through a stimuli responsive linker by covalent binding 
method. NOR covalent binding with INH is shown in Fig. 1.
H37Rv strain, of MTB received from National institute for Research in TB 
(NIRT) was used as the standard strain. The Institute Ethical Committee 
approval was obtained and informed consent were received from the 
TB patients. A sensitive strain and resistant strain were identified from 
the sputum received from the patients. H37Rv, sensitive strain and 
resistant strain were grown in Lowenstein Jensen (LJ) medium.
Drug preparation
As per the ICMR MANUAL 20 mg of NOR-polyethylene glycol [PEG]-
INH was dissolved in 20 ml of sterile distilled water to make up 
10,000 µg/ml which serves as a stock solution, from the stock 
solution working solution was prepared by further dilution. The stock 
solution was maintained at −20°C, working solution was used for the 
incorporation of the drug into LJ’s medium.
ACM
To calculate efficacy of the drugs, DST was performed using ACM. 
The following concentration of anti-TB nanodrugs was used in this 
study; 0.025, 0.05, 0.1, 0.2, 0.5, 1, 2.5, and 5 µg/ml for INH. Drug-free 
media and media containing graded concentration of the drugs were 
inoculated with the standard strain H37Rv of MTB, sensitive strain and 
a resistant strain and readings were taken on 28th day [14].
Phage propagation (MP)
MP buffer was prepared. 500 µl of phage buffer was added in cryovial. 
50 µl of the phage was added in the first vial and 50 µl to the next. The 
phages were diluted up to the desired dilution in the same buffer. 500 µl 
of bacterial suspension (Mycobacterium smegmatis) equivalent to 2-3 
McFarlands standard to the last three dilutions were added and incubated 
at 37°C for 30 minutes. After incubation, 200 µl from each dilution was 
taken and mixed with 5 ml of soft agar separately and poured on to the 
7H9 base medium, the plates were incubated at 37°C for 18-24 hrs. The 
plates showing lacey pattern of plaque formation was chosen to harvest 
the phages. 5 ml of MP buffer was added to the plates, shaken for 2 hrs 
at room temperature in rotatory shaker (~ 80RPM). The buffer was 
aspirated and filtered using 0.45 µm membrane filter. The dilution was 
marked in which phages harvested with date and stored at 4°C [15].
LRP DST
From the culture suspension prepared for DST LRP (DLRP), 100 µl was 
transferredto 4 sterile cryovials. 400 µl of 7H9 medium was added to all 
the four vials (Two vials serves as blank and third vial for INH and fourth 
vial for NOR+PEG+INH). Mix and incubate at 37°C for 72 hrs.50 µl of 
phAETRC21 and 20 µl of 0.1 M CaCl2 were added to all vials. Incubated 
at 37°C for 4 hrs.100 µl of the cell-phage mixture was transferred to a 
luminometer cuvette. 100 µl of D-Luciferin was added and reduction in 
light units (RLU) was immediately measured at 10 seconds integration. 
Luminometer cuvette was discarded in to the lysol bath [16].
The percentage reduction in RLU was calculated using:




The nanocarriers with anti-TB drugs were validated using scanning 
electron microscope and atomic force microscopy for their size in IISER 
Kolkata [13]. INH was dissolved in distilled water.
Minimum inhibitory concentration (MIC) of three strains with plain TB 
drugs and NOR based TB drugs showed that NOR+PE+-INH showed 
anti-TB activity with lower concentration. The LJ medium bottles 
used for ACM were shown in Fig. 2. The significant antimycobacterial 
activity of NOR+PEG+INH of the sensitive strains and resistant 
strains in comparison with INH were explained in Table 1. NOR based 
nanaocarriers have a capacity to interact with antituberculous drugs 
and form a copolymer. The presence of antimycobacterial activity of 
NOR+PEG+INH against MTB indicates that the formed copolymer does 
not affect the original mechanism of anti-TB activity of the drug INH. The 
copolymer and the anti-TB drugs directly interact with MTB the results 
were similar to that of another study done using analogue of INH [16].
In ACM NOR+PEG+INH on resistant strain, no inhibitory action was 
observed. INH losses their activity while binding to egg proteins, 
which are the ingredients of LJ medium [17]. Alternative DST 
method of MP with luciferin was used in this study. The plate which 
is used for harvesting phages was shown in Fig. 3. LRPs has various 
advantages such as less time-consuming and do not involve any tedious 
Fig. 1: Chemical structure of norbornene linked with isoniazid
Fig. 2: Drug susceptibility testing performed in Lowenstein Jensen 
medium using absolute concentration method
Fig. 3: Plate showing lacey pattern
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work [18-20]. Emission of light in a sample infected with phages and 
supplemented with luciferin indicates the presence of viable bacterial 
cells [21]. In our study, viable cells were less compared to drug-free 
control; this proves that the compound is active.
LRP assay results shows that INH along with NOR has a better 
antimycobacterial activity compared to plain INH which is shown in 
Table 2 and proved that anti-TB drugs along with nanocarrier are stable 
under extracellular conditions. Strains exhibiting a reduction of less 
than 50% relative light units in the drug containing vial compared to 
control were classified as resistant. The resistant strain was inhibited 
by NOR+PEG+INH at a rate of 37% compared to plain INH which had 
a inhibition rate of 24% thus by further standardizing the inhibitory 
activity of NOR+PEG+INH can be increased at a higher rate.
Cytotoxicity assay of anti-TB drugs done in IISER proved that at lower 
concentrations of the drug, the cytotoxicity could not attribute to 
damage to cytoplasmic, endosomal and lysosomal membranes, and 
normal human cell death can be prevented when exposed to NOR [11]. 
The nanodrug conjugates have high drug loading efficiency up to 58-
95%, so that more amounts of drugs which is proposed to act on target 
site can be loaded [22]. In vivo activity using Thp1 cell line for the 
promising drug delivery is in process.
CONCLUSION
The antimycobacterial susceptibility testing of nanocarrier with anti-
TB drugs revealed that NOR-based INH with 74% of INH has lower 
MIC value. The predominant anti-TB drug INH plays a major role in 
treatment of TB infection both in intensive and continuous phase. 
Thus, enhancing activity of INH with NOR conjugates appreciated as 
a welcoming step. The nanosized polymers with anti-TB drugs are 
expected on future treatment for TB infection.
ACKNOWLEDGMENTS
The authors are grateful to acknowledge SRM University, Kanchipuram 
for the facilities to carry out the research, IISER Kolkata for providing 
the nanocarrier with drugs for the study and NIRT for providing TB 
strains and valuable suggestions toward the study.
REFERENCES
1 Fivy K, Syed AS, Syed WG. Study on drug-resistant tuberculosis and 
tuberculosis treatment on patients with drug resistant tuberculosis 
in chest clinic outpatient department. Int J Pharm Pharm Sci 
2012;4:733-7.
2. Dutta PK, Das JK. An overview of information, education and 
communication (IEC) activities in revised national tuberculosis control 
programme (RNTCP) and role of NGOs. Indian J Prev Soc Med 
2012;43(4):366-71.
3. Amit D, Dharmeshkumar P. A profile of adverse effects of anti-
tubercular drugs. GCSMC J Med Sci 2016;1:37-41.
4. Schaberg T, Rebhan K, Lode H. Risk factors for side-effects of 
isoniazid, rifampin and pyrazinamide in patients hospitalized for 
pulmonary tuberculosis. Eur Respir J 1996;9(10):2026-30.
5. Orme IM Development of new vaccines and drugs for TB: Limitations 
and potential strategic errors. Future Microbiol 2011;6(2):161-77.
6. Dye C, Espinal MA. Will tuberculosis become resistant to all 
antibiotics? Proc Biol Sci 2001;268(1462):45-52.
7. Sosnik A, Carcaboso AM, Glisoni RJ, Moretton MA, Chiappetta DA. New 
old challenges in tuberculosis: Potentially effective nanotechnologies in 
drug delivery. Adv Drug Deliv Rev 2010;62(4-5):547-59.
8. Ruckmani K, Kumaresan C. Sustained release aerosol for 
pulmonary drug delivery system: A review. Int J Pharm Pharm Sci 
2013;5:126-30.
9. Pandey R, Khuller GK. Subcutaneous nanoparticle-based antitubercular 
chemotherapy in an experimental model. J Antimicrob Chemother 
2004;54(1):266-8.
10. Mane SR, Dinda H, Sathyan A, Das Sarma J, Shunmugam R. Increased 
bioavailability of rifampicin from stimuli-responsive smart nano 
carrier. ACS Appl Mater Interfaces 2014;6(19):16895-902.
11. Vijayakameshwara RN, Shivshankar RM, Abhinoy K, Jayasri DS, 
Raja S. Norbornene derived doxorubicin copolymers as drug 
carrires with pH responsive hydrazone linker. Biomacromolecules 
2012;13:221-30.
12. Shivshankar RM, Vijayakameswara RN, Raja S. Reversible pH and lipid 
sensitive vesicles from amphiphilic norbornene-derived thiobarbiturate 
homopolymers. ACS Macrolett 2011;1:482-8.
13. Shivshankar RM, Koushik C, Himari D, Jayasri DS, Raja S. Stimuli 
responsive nanocarrier for an effective delivery of multifrontline 
tuberculosis drugs. Polym Chem 2014;5:2725-35.
14. NIRT Manual. Standard Protocols for Mycobacteriology Laboratory, 
Version 1.1, November; 2010.
15. Azger D, Vanaja K, Narayana PR. Constructiona and evaluation of 
luciferase reporter phages for detection of active and non-replicating 
tubercle bacilli. J Microbiol Methods 2009;7(31):18-25.
16. Sarvamangala D, Nagasejitha P, Phrabu S, Srinivas L, Murthy US. 
Preparation and evaluation of isoniazid nano-conjugates for improving 
the therapeutic efficiency. Int J Pharm Sci Res 2015;6:739-45.
17. Jacob WR, Bartella RG, Udani R, Kalkut T, Sarkis GJ, Hatfull GF, 
et al. Rapid assessment of drug susceptibility testing of Mycobacterium 
tuberculosis by means of luciferase reporter phage. Science 
1993;260:819-22.
18. Sarkis GJ, Jacobs WR Jr, Hatfull GF. L5 luciferase reporter 
mycobacteriophages: A sensitive tool for the detection and assay of live 
mycobacteria. Mol Microbiol 1995;15(6):1055-67.
19. Schlossberg D. Tuberculosis: A Sourcebook for Nursing Practice. 
New York: Springer Publications; 1995.
20. Banaiee N, Bobadilla V, Osornio JS, Luciferase reporter 
mycobacteriophages for detection, identification and antibiotic 
susceptibility testing of MTB in Mexico. J Clin Microbiol 
2001;39:3883-8.
21. Suarez S, O’Hara P, Kazantseva M, Newcomer CE, Hopfer R, 
McMurray DN, et al. Airways delivery of rifampicin microparticles 
for the treatment of tuberculosis. J Antimicrob Chemother 
2001;48(3):431-4.
22. Sharma A, Sharma S, Khuller GK. Lectin-functionalized poly 
(lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular 
drug carriers for treatment of tuberculosis. J Antimicrob Chemother 
2004;54(4):761-6.
Table 1: MIC of plain and NOR conjugate with INH by ACM
Control and clinical strains MIC of Anti‑TB drugs
Plain INH NOR+PEG+INH
H37Rv 0.025 µg/ml 1 µg/ml
Sensitive strain 0.5 µg/ml 1 µg/ml
Resistant strain 2.5 µg/ml 5 µg/ml
TB: Tuberculosis, MIC: Minimum inhibitory concentration, NOR: Norbornene, 
PEG: Polyethylene glycol, INH: Isoniazid, ACM: Absolute concentration method
Table 2: DST for the resistant strain using luciferase reporter 
MPs
Strains Solvent control INH (0.2 µg/ml)
Control 1 Control 2 Plain INH NOR+PEG+INH
Resistant 
strain
1269 RLU 750 RLU 760 RLU (24%) 625 RLU (37%)
DST: Drug susceptibility testing, INH: Isoniazid, NOR: Norbornene, 
PEG: Polyethylene glycol, RLU: Reduction in light units, 
MPs: Mycobacteriophages
